|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 31/14 | |
| A61K 31/40 | |||
| C07D 207/27 | |||
| C07D 207/452 | |||
| C07D 295/00 |
| (11) | Number of the document | 1505963 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03731248.5 |
| Date of filing the European patent application | 2003-05-20 | |
| (97) | Date of publication of the European application | 2005-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2011-04-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2003/015755 |
| Date | 2003-05-20 |
| (87) | Number | WO 2003/099274 |
| Date | 2003-12-04 |
| (30) | Number | Date | Country code |
| 382055 P | 2002-05-20 | US |
| (72) |
WANG, Xiangdong, Alan, US
SUN, Li-Quang, US
SIT, Sing-Yuen, US
SIN, Ny, US
SCOLA, Paul, Michael, US
HEWAWASAM, Piyasena, US
GOOD, Andrew, Charles, US
CHEN, Yan, US
CAMPBELL, Jeffrey, Allen, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road P.O. Box 4000, Princeton NJ 08543-4000,
US
|
| (54) | HEPATITIS C VIRUS INHIBITORS |
| HEPATITIS C VIRUS INHIBITORS |